Aortic Sinus Contrast Retention During TAVR: A Warning Sign Preceding a Potential Thrombotic Complication.

AF, atrial fibrillation CT, computed tomography STJ, sinotubular junction STS, Society of Thoracic Surgeons SoV, sinus of Valsalva TAVR, transcatheter aortic valve replacement stroke thrombosis transcatheter aortic valve replacement

Journal

JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292

Informations de publication

Date de publication:
01 Jun 2022
Historique:
received: 23 02 2022
accepted: 28 03 2022
entrez: 9 6 2022
pubmed: 10 6 2022
medline: 10 6 2022
Statut: epublish

Résumé

Sinus contrast material retention after transcatheter aortic valve replacement (TAVR) is a rare phenomenon that may reflect an increased risk for thrombotic complications. We present 3 cases of persistent contrast agent retention in the sinus of Valsalva during the TAVR procedure that portend the occurrence of embolic stroke or bioprosthetic valve thrombosis. (

Identifiants

pubmed: 35677788
doi: 10.1016/j.jaccas.2022.03.031
pii: S2666-0849(22)00276-5
pmc: PMC9168964
doi:

Types de publication

Case Reports

Langues

eng

Pagination

666-670

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

Drs Asmarats, Millan, and Arzamendi have received proctoring and speaker fees from Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Références

Front Cardiovasc Med. 2018 Jul 31;5:104
pubmed: 30109235
Eur J Cardiothorac Surg. 2017 May 1;51(5):927-935
pubmed: 28100471
J Thorac Cardiovasc Surg. 2022 Apr;163(4):1309-1315
pubmed: 34556359
J Thromb Thrombolysis. 2022 Jan;53(1):191-201
pubmed: 34128199
JACC Cardiovasc Imaging. 2016 Dec 8;:
pubmed: 28017712
Open Heart. 2019 Nov 21;6(2):e001132
pubmed: 31803486

Auteurs

Lluis Asmarats (L)

Department of Cardiology, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Chi-Hion Li (CH)

Department of Cardiology, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Xavier Millán (X)

Department of Cardiology, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Irene Menduiña (I)

Department of Cardiology, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Estefanía Fernández-Peregrina (E)

Department of Cardiology, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Lola Gutiérrez-Alonso (L)

Department of Cardiology, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Mario Torres (M)

Department of Cardiology, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Antonio Serra (A)

Department of Cardiology, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Dabit Arzamendi (D)

Department of Cardiology, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Classifications MeSH